Grufity logo
Grufity logo

Latest Artia Global Partners LP Stock Portfolio

$541Million | No. of Holdings #48

Artia Global Partners LP Performance

2026 Q2+5.87%
YTD-0.67%
2025+43.83%

About Artia Global Partners LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Artia Global Partners LP reported an equity portfolio of $541.9 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Artia Global Partners LP are , INSM, TRVI. The fund has invested 12.7% of it's portfolio in ABIVAX SA and 11.6% of portfolio in INSMED INC. <br><br> The fund managers got completely rid off ELI LILLY & CO (LLY), TERNS PHARMACEUTICALS INC (TERN) and ASCENDIS PHARMA A/S (ASND) stocks. They significantly reduced their stock positions in INSMED INC (INSM) and ALUMIS INC. Artia Global Partners LP opened new stock positions in ALKERMES PLC (ALKS), SPDR SERIES TRUST (BIL) and GUARDANT HEALTH INC (GH). The fund showed a lot of confidence in some stocks as they added substantially to BRIGHTSPRING HEALTH SVCS INC, TRAVERE THERAPEUTICS INC (TVTX) and CYTOKINETICS INC (CYTK).
Artia Global Partners LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$541Million
  as of Aug 14, 2026

Artia Global Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Artia Global Partners LP made a return of 5.87% in the last quarter. In trailing 12 months, it's portfolio return was 19.67%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
alkermes plc23,523,500
spdr series trust15,825,000
guardant health inc5,716,140
absci corporation5,382,910
ascendis pharma a/s4,731,610
oruka therapeutics inc3,178,680
compass therapeutics inc839,208
spyre therapeutics inc355,120
New stocks bought by Artia Global Partners LP

Additions

Ticker% Inc.
brightspring health svcs inc861
travere therapeutics inc379
cytokinetics inc333
celcuity inc280
enliven therapeutics inc244
quest diagnostics inc59.55
edgewise therapeutics inc50.84
revolution medicines inc48.32
Additions to existing portfolio by Artia Global Partners LP

Reductions

Ticker% Reduced
insmed inc-35.16
alumis inc-14.31
abivax sa-14.03
Artia Global Partners LP reduced stake in above stock

Sold off

Ticker$ Sold
terns pharmaceuticals inc-5,525,060
soleno therapeutics inc-2,293,040
eli lilly & co-35,153,600
avalo therapeutics inc-432,522
bridgebio pharma inc-1,514,900
ascendis pharma a/s-4,057,670
abbvie inc-3,153,600
apogee therapeutics inc-495,425
Artia Global Partners LP got rid off the above stocks

Sector Distribution

Artia Global Partners LP has about 54.6% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare54.6
Others45.4

Market Cap. Distribution

Artia Global Partners LP has about 25.9% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
  • MEGA-CAP
Category%
UNALLOCATED45.4
MID-CAP24.6
LARGE-CAP23.7
SMALL-CAP4.1
MEGA-CAP2.2

Stocks belong to which Index?

About 48.2% of the stocks held by Artia Global Partners LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others51.7
RUSSELL 200042.8
S&P 5005.4
Top 5 Winners (%)%
RVMD
revolution medicines inc
67.3 %
TRVI
trevi therapeutics inc
52.5 %
TVTX
travere therapeutics inc
40.5 %
rapport therapeutics inc
33.2 %
kiniksa pharmaceuticals intl
32.8 %
Top 5 Winners ($)$
TRVI
trevi therapeutics inc
14.2 M
RVMD
revolution medicines inc
14.0 M
abivax sa
12.2 M
brightspring health svcs inc
7.7 M
ARGX
argenx se
5.9 M
Top 5 Losers (%)%
INSM
insmed inc
-28.7 %
TENX
tenax therapeutics inc
-9.0 %
UTHR
united therapeutics corp del
-8.6 %
CELC
celcuity inc
-5.4 %
astrazeneca plc
-3.8 %
Top 5 Losers ($)$
INSM
insmed inc
-42.6 M
astrazeneca plc
-0.7 M
CELC
celcuity inc
-0.4 M
UTHR
united therapeutics corp del
-0.3 M
BLTE
belite bio inc
-0.1 M

Artia Global Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Artia Global Partners LP

Artia Global Partners LP has 48 stocks in it's portfolio. About 64.5% of the portfolio is in top 10 stocks. INSM proved to be the most loss making stock for the portfolio. TRVI was the most profitable stock for Artia Global Partners LP last quarter.

$541.86MTotal Value
56.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Artia Global Partners LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ARGX
Argenx Se

Argenx Se

ARGX
Artia Global Partners LP's holding in Argenx Se over time
5.09%29,739
$27.59M
5.09%
unchanged 0 percentunchanged
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Artia Global Partners LP's holding in Ascendis Pharma A/S over time
0%0.00
$0.00
0%
decreased 100 percentsold off
BIL
Spdr Series Trust

Spdr Series Trust

BIL
Artia Global Partners LP's holding in Spdr Series Trust over time
2.92%100,000
$15.82M
2.92%
new position
BLTE
Belite Bio Inc

Belite Bio Inc

BLTE
Artia Global Partners LP's holding in Belite Bio Inc over time
0.71%24,989
$3.85M
0.71%
unchanged 0 percentunchanged
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Artia Global Partners LP's holding in Bright Minds Biosciences Inc over time
0.5%38,407
$2.70M
0.5%
unchanged 0 percentunchanged